Community Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Social Determinants of Health Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Functional Neurosurgery Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Biomol Biomed. 2024 May 2;24(3):659-664. doi: 10.17305/bb.2023.9748.
Assessing the impact of coronavirus disease 2019 (COVID-19) reveals unique challenges for pregnant women, who experience distinct clinical manifestations and health outcomes compared to their non-pregnant counterparts. We aimed to evaluate the clinical features, disease severity, and health outcomes of COVID-19 in pregnant women and compare them to those of non pregnant women. In this population-based study, we included all women diagnosed with COVID-19 across the province of Tehran during the first two years of the epidemic. Descriptive statistics, the chi-squared test, and the logistic regression model were applied. Overall, 79,338 non-pregnant women and 3249 pregnant women diagnosed with COVID-19 were included. Pregnant women were most commonly in the age group of 25 - 34 years (54%, n = 1758), while the age group of 34-44 had the highest representation among non-pregnant women (56%, n = 44,492). After accounting for age and comorbidities, pregnancy was associated with an increased risk of requiring intensive care (odds ratio [OR] 1.38, confidence interval [CI] 1.223 - 1.564). However, the probability of dying due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was lower in pregnant women compared to non-pregnant women (OR 0.55, CI 0.394-0.793). Cough (41%) and fever (30%) were the most frequent clinical presentations in pregnant women, whereas cough (57%) and muscle ache (38%) were the most common symptoms in non-pregnant women. Furthermore, diarrhea (P < 0.001) and skin lesions (P < 0.001) were reported more frequently by pregnant patients than non-pregnant patients. A significant prevalence of diabetes (P < 0.001), hypertension (P < 0.001), cancers (P < 0.001), and chronic hematological diseases (P < 0.001) was observed in pregnant patients. In conclusion, COVID-19-infected pregnant women exhibit different clinical manifestations and a more severe clinical course but have better health outcomes compared to their non-pregnant counterparts.
评估 2019 年冠状病毒病(COVID-19)对孕妇的影响揭示了独特的挑战,与非孕妇相比,孕妇的临床表现和健康结局明显不同。我们旨在评估 COVID-19 孕妇的临床特征、疾病严重程度和健康结局,并将其与非孕妇进行比较。在这项基于人群的研究中,我们纳入了 COVID-19 疫情期间德黑兰省所有被诊断为 COVID-19 的孕妇。应用描述性统计、卡方检验和逻辑回归模型。共有 79338 名非孕妇和 3249 名孕妇被诊断为 COVID-19。孕妇最常见的年龄组为 25-34 岁(54%,n=1758),而非孕妇中年龄组为 34-44 岁的比例最高(56%,n=44492)。在考虑年龄和合并症后,妊娠与需要重症监护的风险增加相关(比值比[OR]1.38,95%置信区间[CI]1.223-1.564)。然而,与非孕妇相比,孕妇因严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染而死亡的概率较低(OR0.55,95%CI0.394-0.793)。孕妇最常见的临床表现为咳嗽(41%)和发热(30%),而非孕妇最常见的症状为咳嗽(57%)和肌肉疼痛(38%)。此外,孕妇腹泻(P<0.001)和皮肤损伤(P<0.001)的报告频率高于非孕妇。孕妇中糖尿病(P<0.001)、高血压(P<0.001)、癌症(P<0.001)和慢性血液疾病(P<0.001)的患病率显著较高。总之,与非孕妇相比,COVID-19 感染孕妇的临床表现不同,临床过程更严重,但健康结局更好。